ziconotide   Click here for help

GtoPdb Ligand ID: 2536

Synonyms: ω-conotoxin MVIIA | Prialt® | SNX-111
Approved drug
ziconotide is an approved drug (FDA (2004), EMA (2005))
Comment: Ziconotide is the INN for synthetically produced ω-conotoxin which was identified and extracted from the venom of Conus magus (Magus cone or Magician's cone snail).
Click here for help
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NCCCCC1NC(=O)C(C)NC(=O)CNC(=O)C(CCCCN)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(N)CSSCC2C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC3CSSCC(NC1=O)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(Cc1ccc(cc1)O)C(=O)NC(CC(=O)O)C(=O)NC(C(=O)N2)CSSCC(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC3=O)CCCNC(=N)N)CO)CCCCN)C(=O)N)CO)C(O)C
Isomeric SMILES NCCCC[C@@H]1NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@H]2C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N2)CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC3=O)CCCNC(=N)N)CO)CCCCN)C(=O)N)CO)[C@H](O)C
InChI InChI=1S/C102H172N36O32S7/c1-50(2)34-63-91(161)127-62(26-33-171-5)90(160)129-64(35-53-22-24-54(143)25-23-53)92(162)130-65(36-78(148)149)93(163)135-72-48-175-173-45-69(80(108)150)133-86(156)58(18-8-12-29-105)121-76(146)39-117-85(155)66(41-139)131-88(158)61(21-15-32-114-102(111)112)126-96(166)70-46-176-177-47-71(97(167)132-68(43-141)95(165)125-60(87(157)128-63)20-14-31-113-101(109)110)134-89(159)59(19-9-13-30-106)123-81(151)51(3)119-74(144)37-115-83(153)56(16-6-10-27-103)120-75(145)38-116-84(154)57(17-7-11-28-104)124-82(152)55(107)44-172-174-49-73(137-98(72)168)99(169)138-79(52(4)142)100(170)118-40-77(147)122-67(42-140)94(164)136-70/h22-25,50-52,55-73,79,139-143H,6-21,26-49,103-107H2,1-5H3,(H2,108,150)(H,115,153)(H,116,154)(H,117,155)(H,118,170)(H,119,144)(H,120,145)(H,121,146)(H,122,147)(H,123,151)(H,124,152)(H,125,165)(H,126,166)(H,127,161)(H,128,157)(H,129,160)(H,130,162)(H,131,158)(H,132,167)(H,133,156)(H,134,159)(H,135,163)(H,136,164)(H,137,168)(H,138,169)(H,148,149)(H4,109,110,113)(H4,111,112,114)/t51-,52+,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,79-/m0/s1
InChI Key BPKIMPVREBSLAJ-QTBYCLKRSA-N
Bioactivity Comments
Bioactivity data may have been generated using either the mollusc-derived peptide or the synthetically manufactured version.
Selectivity at ion channels
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Cav2.2 Rn Channel blocker Antagonist 7.7 – 10.3 pIC50 - 2,5
pIC50 7.7 – 10.3 [2,5]
Voltage: Physiological
Cav2.1 Rn Channel blocker Antagonist 6.3 pIC50 - 5
pIC50 6.3 [5]
Voltage: Physiological
Cav2.2 Hs Channel blocker Antagonist 1.0 pIC50 - 3
pIC50 1.0 [3]
Voltage: -90.0 mV
Targets where the ligand is described in the comment field
Target Comment